fbpx
Medical Innovation Exchange

Merck strikes 2nd ADC deal with Kelun-Biotech, paying $35M for rights to unnamed asset

https://www.fiercebiotech.com/biotech/merck-strikes-second-adc-deal-kelun-biotech-paying-35m-rights-unnamed-asset

Leave a Comment

Your email address will not be published.

Leave the field below empty!

This site uses Akismet to reduce spam. Learn how your comment data is processed.